Netflix debuts ‘Rebel Moon’ teaser, Zack Snyder’s two-part sci-fi epic

Netflix released the official teaser trailer for “Rebel Moon,” a space fantasy film directed by “Justice League” filmmaker Zack Snyder, arriving on the streaming service on December 22.

Notably, this is only the first part of the film, which is titled “Rebel Moon Part 1: A Child of Fire.” Netflix is set to release a second part of the film, “Rebel Moon Part 2: The Scargiver,” on April 19, 2024. The reason for the split is that the film would be approximately three hours in length, which Netflix film chairman Scott Stuber advised against; movies that are under two hours perform better on the streamer, per Vanity Fair.

“Rebel Moon” features “Kingsman: The Secret Service” actress Sofia Boutella as Kora, a mysterious warrior who defends a colony located on the edge of the galaxy that is threatened by Regent Balisarius (played by Ed Skrein) and the Mother World army. Kora recruits a small band of misfits from neighboring planets to help defeat the tyrannical ruling force.

The film also stars Anthony Hopkins, Charlie Hunnam, Michiel Huisman, Djimon Hounsou, Staz Nair, Bae Doona, Ray Fisher and more.

Zack Snyder’s ‘Rebel Moon’ is set to arrive on Netflix in December



from TechCrunch https://ift.tt/mQO6neC
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more